Term
|
Definition
exp in drug compounding
Galenicals |
|
|
Term
|
Definition
first official pharmacopia
collaboration of guild of apothecaries and med society |
|
|
Term
| Societies of Apothecaries of London |
|
Definition
|
|
Term
|
Definition
Philly
Elizabeth marshal becomes first woman pharmacist in US
became a training school |
|
|
Term
|
Definition
first alkoloid chemist
morphine from opium |
|
|
Term
|
Definition
father of American Pharmacy
APA
served on USP |
|
|
Term
| Stanardization fo Pharmacuetics |
|
Definition
1883
first list of 20 standardized liquids |
|
|
Term
|
Definition
|
|
Term
|
Definition
antispasmodic for GI
helps with eye exams (pupils dialate) |
|
|
Term
|
Definition
|
|
Term
|
Definition
stimulant
used in weight loss supplements |
|
|
Term
|
Definition
| antioxidant and anti-inflamatory |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
stops maternal bleeding after childbirth
partial treatment of migranes |
|
|
Term
|
Definition
Sulfa-Drugs
fights bacterial infections |
|
|
Term
|
Definition
Chem substance used in treatment, cure, prevention or diagnosis of a disease or otherwised used to enhance physical or mental well-being
in pharmacopia
affects structure or function of body |
|
|
Term
|
Definition
treats a diseas by administration of minute doses of drug that produce similar symptoms
like cures like
induce symptoms, flush out symptoms, become healthy |
|
|
Term
|
Definition
contain more than 1 ingredient
supplement ones diet
vitamins, minerals, herbs, botanicals, amino acids |
|
|
Term
| United States Pharmacopia |
|
Definition
USP: standars for medicines, dosage forms, drug substances, exipients, medical devices, and dietary supplements
NF: the book that contains the exipients and formulas for making the preparations |
|
|
Term
| Homeopathic Pharmacopeia of US |
|
Definition
HPUS
official standards for homeopathic medicines
data on safety and efficacy |
|
|
Term
|
Definition
US dept of health and human services
regulate and supervise safety
regulate advertising
protect agains misbranding and adultering |
|
|
Term
|
Definition
made on lable
must be approved for exact wording! |
|
|
Term
|
Definition
changing the strenght, purity, or quality
-can be from contamination |
|
|
Term
|
Definition
1906
products had to be labled correctly
focused on misbranding and adulterating |
|
|
Term
| Food, Drug and Cosmetic Act |
|
Definition
1938
FDCA
approval of new drugs ,med devices, and costmetics
had to have adequate directions
WARNINGS must be present |
|
|
Term
| Durham-Humphrey Admendment |
|
Definition
1951
Prescription drug amendment
difference between OTC and Rx |
|
|
Term
| Kefauver-Harris Amendment |
|
Definition
1962
Drug Efficacy
established GMP
products had to be safe and effective |
|
|
Term
|
Definition
1983
Gave incentives to manufacturers to develop high expense drugs for chronic diseases |
|
|
Term
| Drug Price Competition and Patent-Term Restoration Act |
|
Definition
1984
streamline generic drug process
incentives for making new drugs |
|
|
Term
| Prescription Drug Marketing Act |
|
Definition
1987
recordkeeping and requirements for samples
porhibits reselling pharm purchases |
|
|
Term
|
Definition
1997
streamlining of regulations
FDA had to define scope or responsibility |
|
|
Term
|
Definition
ensures safety, adequate directions, appropriate expiration dating, and tamper-evident packaging
FTC regulates advertising for OTC procuts |
|
|
Term
| Dietary Supplement Health and Education Act |
|
Definition
1994
DSHEA
-FDA must prove that product is unsafe before removing it from market |
|
|
Term
| Components of Package Insert |
|
Definition
| Decsription, chem structure, mech of action, pharm-kinetics, clinical studies, indication, contraindications, warnings, precations, pregnacny cats, special pops, adverse reactions, dosage administration, how supplied,how stored, manufacturer, date last revised |
|
|
Term
|
Definition
-no risk in animals
-no evidence of risk in humans |
|
|
Term
|
Definition
-no evidence in animal study
-no adequate human studies
-no evidence of risk |
|
|
Term
|
Definition
-animal studies show risk
-no adequate studies in humans
-benefits may outweigh risks |
|
|
Term
|
Definition
-positive in animals
-positive in humans for adverse affects
benefits may outweigh RISKS |
|
|
Term
|
Definition
-Animal Studies show abnormalities
-Human fetus shows abnormalities
-benefits DO NOT outweigh risks |
|
|
Term
|
Definition
1970
enforced by DEA
5 categories for potential for abuse and accepted med usage |
|
|
Term
|
Definition
-can prescribe without DEA if working under another doctor with a valid DEA
-1st letter = A or B (most likely B)
-2nd letter is last name
-7 numbers |
|
|
Term
|
Definition
| Lawful order from a practitioner for a drug or device for a specific patient that is communicated firectly to a pharmacist in a licensed pharmacy |
|
|
Term
|
Definition
Patients in hospitals
Destined for administration to patient |
|
|
Term
| Components of Prescriptions (NON-CONTROLLED) |
|
Definition
| Name, Date, Prescriber, DRUG (name, strenght, dosage form, quantity), SIG, refills, signature |
|
|
Term
| COMPONTENTS OF A PRESCRIPTION ( CONTROLLED) |
|
Definition
all of the non-controlled plus
DEA#, written out, PT address, date and quantity written out! |
|
|
Term
|
Definition
No legal requirements
good practice: (height and weight, dosage schedule, prescriber ID, Pt location, date and time) |
|
|
Term
| Components of a prescription lable (Inpatient) |
|
Definition
| name or product, route of administration, strenght and concentration, volume, control/lot #, ID of packager, special conditions, beyond use date |
|
|
Term
| Components of Prescription Lable (OUTPATIENT) |
|
Definition
| name and adress of pharmacy, pt name, prescribers name, directions, date dispensed, cautionary statements, Rx ID#, name and strenght of drug, manufacturer name, expiration date, quantity, refills |
|
|
Term
|
Definition
U=unit
IU=international unit
QD= once daily
QOD= every other day
X.0 mg= X mg
MS=morphine sulfate or magnesium sulfate
<,>
drug name abbreviations
apothecary units
@,cc,ug |
|
|
Term
|
Definition
| the responsible provision of drug therapy for the purpose of acheiving definite outcomes that improve a patients quality of life |
|
|
Term
| 1st Element of Pharmaceutical Care |
|
Definition
| Responsive provision of care |
|
|
Term
| 2nd element of pharm care |
|
Definition
|
|
Term
| 3rd element of pharm care |
|
Definition
|
|
Term
| 4th element of pharm care |
|
Definition
| Acheiving positive outcomes |
|
|
Term
| 5th Element of Pharm Care |
|
Definition
| improving the patients of QoL |
|
|
Term
| 6th Element of Pharm Care |
|
Definition
| -resolution of medcation-related problems |
|
|
Term
| Six Types of medication-related problems |
|
Definition
1. unnecessary medication therapy
2. additional medication therapy warranted
3. Wrong Medication
4.Dose too high/low
5.Adverse Drug Reaction (ADR)
6.Non-Adherence |
|
|
Term
| 4 Major Steps towars pharmaceutical care process |
|
Definition
1. identify problem
2. establish treatment goals
3. Create a care plan
4.Monitor and follow-up |
|
|
Term
|
Definition
History and phsyical
cheif complaint
demographics
past med history
family history
social history
medication history
drug allegies
review of systems (Physical examination)
Lab data/tests |
|
|
Term
|
Definition
| head ears eyes nose throat |
|
|
Term
|
Definition
7 major chemicals checked in blood/urine
Na, K, Cl, HCO3-
Glucose
Creatine
sometimes Ca2+ |
|
|
Term
|
Definition
CBC
white blood cells, hemoglobin, platelets, hematocrit
hematocrti( packed cell volume) |
|
|
Term
| Reasons for Med Documentation |
|
Definition
perm record
review info before next appointment
communication
lecgal record
reimbursement
personal thought process |
|
|
Term
| What Med Documentation Provides |
|
Definition
accurate patient-relation history
current care plan
instructions for next encounter |
|
|
Term
| What med documentation needs to be |
|
Definition
retrievable
available and understandable
clear, concise, true
timely, organize, chronological
legible and non-alterable
confidential |
|
|
